Giving voice to African thought in medical research ethics
- 555 Downloads
In this article, I consider the virtual absence of an African voice and perspective in global discourses of medical research ethics against the backdrop of the high burden of diseases and epidemics on the continent and the fact that the continent is actually the scene of numerous and sundry medical research studies. I consider some reasons for this state of affairs as well as how the situation might be redressed. Using examples from the HIV/AIDS and Ebola epidemics, I attempt to show that the marginalization of Africa in medical research and medical research ethics is deliberate rather than accidental. It is causally related, in general terms, to a Eurocentric hegemony derived from colonialism and colonial indoctrination cum proselytization. I end by proposing seven theses for the critical reflection and appraisal of the reader.
KeywordsAfrica Culture Medical research Western hegemony Marginalization Ethics
- 1.Bodunrin, P.O. 1985. Philosophy in Africa: Trends and perspectives. Ile-Ife: University of Ife Press.Google Scholar
- 2.Hountondji, P.J. 1996. African philosophy: Myth and reality, 2nd ed. Bloomington: Indiana University Press.Google Scholar
- 3.Oruka, H.O. 1990. Sage philosophy: Indigenous thinkers and modern debate on African philosophy. Nairobi: Acts Press, African Center for Technology Studies.Google Scholar
- 7.Tangwa, G.B. 2010. Elements of African bioethics in a Western frame. Mankon: Langaa RPCIG.Google Scholar
- 9.Tutu, D. 1999. No future without forgiveness. New York: Doubleday.Google Scholar
- 10.Tangwa, G.B. 2015. Traditional medicine. In Encyclopedia of global bioethics, ed. H. ten Have, 1–8. Berlin: Springer.Google Scholar
- 11.Mazrui, A.A.A. 1976. A world federation of cultures: An African perspective. New York: The Free Press.Google Scholar
- 14.Tangwa, G.B. 2002. International regulations and medical research in developing countries: Double standards or differing standards? Notizie di Politeia 18 (67): 46–50.Google Scholar
- 15.WHO. 2016. Ebola virus disease . Fact sheet N°103. http://www.who.int/mediacentre/factsheets/fs103/en/. Accessed 2 March 2017.
- 16.WHO. 2014. Ethical considerations for use of unregistered interventions for Ebola virus disease (EVD): Summary of the panel discussion. http://www.who.int/mediacentre/news/statements/2014/ebola-ethical-review-summary/en/. Accessed 2 March 2017.
- 18.Ngu, V.A., and F.A. Ambe. 2001. Effective vaccines against and immunotherapy of the HIV: A preliminary report. Journal of the Cameroon Academy of Science 1 (1): 2–8.Google Scholar
- 19.Ngu, V.A., F.A. Ambe, and G.A. Boma. 2002. Significant reduction of HIV loads in the sera of patients treated with VANHIVAX. Journal of the Cameroon Academy of Science 2 (1): 7–12.Google Scholar
- 20.Ngu, V.A., B.H. Besong-Egbe, F. Ambe, J.A. Ngu, and C. Caspa. 2007. The conversion of HIV sero-positive to sero-negative following VANHIVAX. Journal of the Cameroon Academy of Science 7 (1): 17–20.Google Scholar
- 21.Ngu, V.A., and Tangwa, G.B. 2000. Effective vaccines against and immunotherapy of the HIV: Scientific report and ethical considerations from Cameroon. Paper presented at the Fifth World Congress of Bioethics, Imperial College, London, UK.Google Scholar
- 22.Ngu, V.A., and G.B. Tangwa. 2015. Effective vaccine against and immunotherapy of the HIV: Scientific report and ethical considerations from Cameroon. Journal of the Cameroon Academy of Sciences 12 (2): 76–83.Google Scholar